PatientsVille.com Logo

DYSURIA and Levitra

PatientsVille

DYSURIA Symptoms and Causes

Your kidneys make urine by filtering wastes and extra water from your blood. The waste is called urea. Your blood carries it to the kidneys. From the kidneys, urine travels down two thin tubes called ureters to the bladder. The bladder stores urine until you are ready to urinate. It swells into a round shape when it is full and gets smaller when empty. If your urinary system is healthy, your bladder can hold up to 16 ounces (2 cups) of urine comfortably for 2 to 5 hours.

You may have problems with urination if you have

  • Kidney failure
  • Urinary tract infections
  • An enlarged prostate
  • Bladder control problems like incontinence, overactive bladder, or interstitial cystitis
  • A blockage that prevents you from emptying your bladder

Some conditions may also cause you to have blood or protein in your urine. If you have a urinary problem, see your health care provider. Urinalysis and other urine tests can help to diagnose the problem. Treatment depends on the cause.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Check out the latest treatments for DYSURIA

DYSURIA treatment research studies

Levitra clinical trials, surveys and public health registries


Find Drug Side Effect reports



Levitra Side Effects

Erectile Dysfunction (899)
Headache (338)
Flushing (154)
Dizziness (121)
Nasal Congestion (104)
Vision Blurred (101)
Erection Increased (87)
Adverse Event (67)
Visual Disturbance (60)
Nausea (60)
Visual Acuity Reduced (51)
Chest Pain (47)
Feeling Abnormal (45)
Optic Ischaemic Neuropathy (44)
Dyspnoea (40)
Deafness Unilateral (38)
Visual Field Defect (36)
Dyspepsia (35)
Loss Of Consciousness (35)
Tinnitus (33)
Eye Pain (33)
Eye Disorder (33)
Cerebrovascular Accident (33)
Diarrhoea (30)
Heart Rate Increased (30)
Hypotension (29)
Blood Pressure Decreased (29)
Photopsia (27)
Feeling Hot (26)
Myocardial Infarction (26)
Vomiting (25)
Penile Pain (25)
Fatigue (24)
Ejaculation Failure (24)
Back Pain (23)
Asthenia (23)
Hypertension (23)
Visual Impairment (22)
Rhinorrhoea (22)
Ocular Hyperaemia (22)
Chest Discomfort (21)
Palpitations (21)
Penis Disorder (21)
Photophobia (21)
Ejaculation Disorder (20)
Chills (20)
Erythema (20)
No Adverse Event (20)
Transient Ischaemic Attack (20)
Fall (20)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

DYSURIA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Study to Assess the Efficacy and Safety of "Pílulas de Lussen®" Compared to the Pyridium® in the Symptomatic Control of Dysuria
Condition: Dysuria
Interventions: Drug: Pílulas de Lussen;   Drug: Pyridium®
Outcome Measures: Visual Analogic Scale and opinion of the investigator.;   Of adverse events related to study medication by the Naranjo Algorithm.
2 Unknown  Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer
Conditions: Hematuria;   Dysuria;   Bladder Cancer
Intervention:
Outcome Measure:
3 Recruiting Randomization of Botox for Stent Pain and Irritative Voiding Symptoms
Conditions: Lower Urinary Tract Discomfort;   Stent Pain
Intervention: Drug: Botox
Outcome Measures: Change in Lower Urinary Tract Discomfort between pre-operative visit date and the stent removal date and two week follow up.;   Post-operative pain - visual analog scale (VAS).;   Post-surgical analgesic requirements
4 Recruiting Survey: Clinical Outcome After Bowel Resection in Women Due to Endometriosis
Condition: Bowel Endometriosis
Intervention: Procedure: laparoscopic colonic surgery
Outcome Measures: pain;   dyspareunia;   Dysuria;   obstipation;   pain during defecation;   rectal bleeding
5 Recruiting Storage Symptom After Laser Prostatectomy
Condition: Prostatic Hyperplasia
Intervention: Procedure: Laser prostatectomy (Photoselective vaporization of the prostate or Holmium laser enucleation of the prostate)
Outcome Measure: the subtotal storage symptom score of the International Prostate Symptom Score (IPSS)
6 Not yet recruiting MEdical Versus SUrgical Treatments of Rectal Endometriosis
Condition: Deep Endometriosis Infiltrating the Rectum
Interventions: Drug: Triptoreline 11.25 i.v.; Estradiol 0.5% percutaneous gel;;   Procedure: rectal shaving; rectal disc excision; colorectal resection;   Drug: Cyproterone acetate 50 mg; estradiol 0.5% percutaneous;   Drug: Estradiol 0.5% percutaneous gel; Cyproterone acetate 50 mg oral
Outcome Measures: Postoperative digestive function;   Unfavorable digestive functional outcome
7 Unknown  Postpartum Dyspareunia Resulting From Vaginal Atrophy
Conditions: Vulvovaginal Atrophy;   Dyspareunia Among Puerperal Women
Intervention: Drug: Estriol 0.1% vaginal cream
Outcome Measures: Prevalence of vulvovaginal atrophy among puerperal women;   Prevalence of dyspareunia among women with puerperal vaginal atrophy.;   Effect of treatment with topical estrogen on dyspareunia.
8 Recruiting Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment
Conditions: Overactive Bladder;   Bladder Cancer;   Synergo
Intervention: Other: Questionnaires, anticholinergic treatment, urodynamic study
Outcome Measures: OAB symptoms severity and urodynamic variables in failed medical treatment patients;   Synergo treatment variables and OAB severity;   OAB severity of symptoms and urodynamic variables in failed medical treatment patients;   OAB treatment satisfaction and urodynamic variables in failed medical treatment patients